Baird Lifts PT on Intuitive Surgical (ISRG) to $600 From $590, Keeps an Outperform Rating

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best stocks to invest in for the long term. On July 23, Baird raised the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $600 from $590, keeping an Outperform rating on the shares.

The firm told investors that it remains a buyer of the stock, as its key performance indicators “continue to fire on all cylinders.”

The same day, Leerink Partners analyst Mike Kratky also reiterated a bullish stance on Intuitive Surgical, Inc. (NASDAQ:ISRG), giving the stock a buy rating.

The analyst expressed optimism about the company’s multiple growth drivers and commercial execution, raising the EPS estimates for the upcoming years to reflect confidence in Intuitive Surgical, Inc.’s (NASDAQ:ISRG) ability to sustain its momentum.

Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.

While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.